SITC: Cellectis’ off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
SITC: Cellectis’ off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows [...]
UPDATED: At the eleventh hour, Woodcock shunned by Biden as Califf becomes FDA commish nominee
UPDATED: At the eleventh hour, Woodcock shunned by Biden as [...]
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump [...]
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares pact in latest quarterly cull
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares [...]
Adaptimmune’s TCR T-cell therapy clears efficacy bar in rare cancers, teeing up landmark solid tumor filing
Adaptimmune’s TCR T-cell therapy clears efficacy bar in rare cancers, [...]
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Using CRISPR to find a new drug target for multiple [...]
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Vaxxinity, hoping to turn bodies into their own drug factories, [...]
Organon keeps pedal to the metal, buying up Forendo in 3rd deal since spinning out of Merck
Organon keeps pedal to the metal, buying up Forendo in [...]
Genentech, Novome team up to study seaweed-controlled oral cell therapies in IBD
Genentech, Novome team up to study seaweed-controlled oral cell therapies [...]
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout
After snapping up Parexel with Goldman Sachs, EQT doubles down [...]